IDERA PHARMACEUTICALS, INC.·4

Dec 12, 8:16 PM ET

IDERA PHARMACEUTICALS, INC. 4

4 · IDERA PHARMACEUTICALS, INC. · Filed Dec 12, 2014

Insider Transaction Report

Form 4
Period: 2014-12-10
Wolf John Peter III
General Counsel
Transactions
  • Award

    Stock Option

    2014-12-10+600,000600,000 total
    Exercise: $3.97Exp: 2024-12-10Common Stock (600,000 underlying)
Footnotes (1)
  • [F1]The option vests with respect to 25% of the underlying shares on the first anniversary of the date of grant and the balance of the underlying shares vests in twelve equal quarterly installments following the first anniversary of the date of grant.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION